MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by Justthenewson Jun 24, 2020 1:26am

135 Views

Post# 31184386

RE:Alberta investing 10 million $ in seology testing

Good report from Global.
I agree from a post earlier, can't MedMira contact the Alberta Govt or Fed govt to let them know MedMora has a product that works and is CANADIAN?

Worse case maybe MedMira should think about marketing their product directly to the population as as an over the counter product if possible. We need to get the sales!!

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features